Neuroblastoma Antibody Study
Conditions
Disseminated Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma
What is the purpose of this trial?
This study is for a continuing treatment for high risk neuroblastoma. This study is called a clinical trial. A clinical trial is a research study involving treatment of a disease in human patients. This study is organized by Children’s Oncology Group (COG). COG is an international research group that conducts clinical trials for children with cancer. More than 200 hospitals in North America, Australia, New Zealand, and Europe are members of COG. It is common to enroll children and adolescents with cancer in a clinical trial that seeks to improve cancer treatment over time. Clinical trials include only people who choose to take part.Participation Guidelines
- Age:
- Up to 30 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- National Cancer Institute (NCI)
- Dates:
- November 2011
- Last Updated:
- February 6, 2013
- Study HIC#:
- 1110009218
Clinicaltrials.gov ID: NCT00026312
Investigators
Nina Kadan-Lottick, MD
Principal Investigator
Nina Kadan-Lottick, MD
Principal Investigator
